MicrobiologybioRxivPreprint
The FDA-approved drug nitazoxanide is a potent inhibitor of human seasonal coronaviruses acting at postentry level: effect on the viral spike glycoprotein
S. Piacentini, A. Riccio, S. Santopolo…·M. G. Santoro
The paper shows nitazoxanide inhibits seasonal coronaviruses by interfering with spike glycoprotein maturation, not affecting viral entry.
DOI 10.1101/2022.07.13.499346